Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Harkin student health bill

This article was originally published in The Tan Sheet

Executive Summary

A bill introduced March 6 by Sens. Tom Harkin, D-Iowa, and Lisa Murkowski, R-Alaska, would "update decades-old federal nutrition standards for snack foods sold in school cafeterias alongside the regular school meals," according to a press release. The "Child Nutrition Promotion and School Lunch Protection Act," S 2592, would also apply those standards to foods sold in vending machines on school grounds. USDA's current standards "limit the sale of so-called foods of minimal nutritional value and only apply to cafeterias during meal times," meaning unhealthy snack foods are available to students at other times of the day, a statement from the Center for Science in the Public Interest explains. Harkin has long championed increasing availability of health foods to students. In 2005, he unveiled legislation that would provide federal funding for fresh fruits and vegetables as free snacks in public schools (1"The Tan Sheet" July 25, 2005, p. 14)...

You may also be interested in...



Harkin Pushes For Supplement Food Stamp Coverage, Increased ODS Funding

Passage of a bill that would make dietary supplements eligible for food stamp coverage is a key item on Sen. Tom Harkin's (D-Iowa) legislative agenda

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100311

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel